23 Results

People

  1. Scher
    Scher
  2. Rathkopf
    Rathkopf
  3. Morris
    Morris
  4. Abida
    Abida
  5. Danila
    Danila
  6. Gopalan
    Gopalan
  7. Slovin
    Slovin
  8. Sawyers
    Sawyers
  9. Schultz
    Schultz
  10. Solit
    Solit

Groups

  1. Department of Medicine (23)
  2. Genitourinary Oncology Service (23)
  3. Solid Tumor Oncology Division (23)
  4. Hematologic Malignancies, Division of (9)
  5. GSK Faculty (8)
  6. Human Oncology and Pathogenesis Program (8)
  7. Tow Center for Developmental Oncology (TCDO) (7)
  8. Center for Hematologic Malignancies (6)
  9. Epidemiology and Biostatistics (6)
  10. Sloan Kettering Institute Postdocs (6)
  1. "article"
  2. "Dana Rathkopf"
Formats
  1. Journal Article (23)
Groups
  1. Department of Medicine (23)
  2. Genitourinary Oncology Service (23)
  3. Solid Tumor Oncology Division (23)
  4. Hematologic Malignancies, Division of (9)
  5. GSK Faculty (8)
  6. Human Oncology and Pathogenesis Program (8)

More Groups

People
  1. Dana Rathkopf (23)
  2. Howard Scher (13)
  3. Michael Morris (9)
  4. Daniel Danila (7)
  5. Wassim Abida (7)
  6. Anuradha Gopalan (6)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (3)
  4. 2020 (2)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. European Urology (4)
  2. Cell (2)
  3. Clinical Cancer Research (2)
  4. European Journal of Cancer (2)
  5. JCO Precision Oncology (2)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. Elsevier Science, Inc. (6)
  2. American Association for Cancer Research (3)
  3. American Society of Clinical Oncology (3)
  4. Cell Press (3)
  5. Elsevier Inc. (2)
  6. American Medical Association (1)

More Publishers

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Marital status, living arrangement, and survival among individuals with advanced prostate cancer in the international registry for men with advanced prostate cancer
    Journal Article

    Chen, N.; McGrath, C. B.; Ericsson, C. I.; Vaselkiv, J. B.; Rencsok, E. M.; Stopsack, K. H.; Guard, H. E.; Autio, K. A.; Rathkopf, D. E.; Enting, D.; more...
    Cancer Epidemiology Biomarkers and Prevention (2024)

    Fulltext@MSK | Save
  • Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
    Journal Article

    Zhao, J. L.; Antonarakis, E. S.; Cheng, H. H.; George, D. J.; Aggarwal, R.; Riedel, E.; Sumiyoshi, T.; Schonhoft, J. D.; Anderson, A.; Mao, N.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality
    Journal Article

    Keegan, N. M.; Vasselman, S. E.; Barnett, E. S.; Nweji, B.; Carbone, E. A.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
    Prostate (2022)

    Fulltext@MSK | Save
  • Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302
    Journal Article

    Wilson, B. E.; Armstrong, A. J.; de Bono, J.; Sternberg, C. N.; Ryan, C. J.; Scher, H. I.; Smith, M. R.; Rathkopf, D.; Logothetis, C. J.; Chi, K. N.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • A phase I study investigating AZD8186, a potent and selective inhibitor of PI3Kβ/δ, in patients with advanced solid tumors
    Journal Article

    Choudhury, A. D.; Higano, C. S.; de Bono, J. S.; Cook, N.; Rathkopf, D. E.; Wisinski, K. B.; Martin-Liberal, J.; Linch, M.; Heath, E. I.; Baird, R. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer
    Journal Article

    Zhang, Z.; Karthaus, W. R.; Lee, Y. S.; Gao, V. R.; Wu, C.; Russo, J. W.; Liu, M.; Mota, J. M.; Abida, W.; Linton, E.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save
  • First-in-human phase I study of a dual mTOR kinase and DNA-PK inhibitor (CC-115) in advanced malignancy
    Journal Article

    Munster, P.; Mita, M.; Mahipal, A.; Nemunaitis, J.; Massard, C.; Mikkelsen, T.; Cruz, C.; Paz-Ares, L.; Hidalgo, M.; Rathkopf, D.; more...
    Cancer Management and Research (2019)

    Fulltext@MSK | Save
  • A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Eisenberger, M.; Heath, E. I.; Bruce, J.; Danila, D. C.; Rathkopf, D. E.; Feldman, J.; Slovin, S. F.; Anand, B.; Chu, R.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save